JP2017512838A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512838A5 JP2017512838A5 JP2017502946A JP2017502946A JP2017512838A5 JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5 JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017502946 A JP2017502946 A JP 2017502946A JP 2017512838 A5 JP2017512838 A5 JP 2017512838A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- seq
- antibody
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2014/074199 | 2014-03-27 | ||
| CN2014074199 | 2014-03-27 | ||
| CNPCT/CN2014/081797 | 2014-07-08 | ||
| CN2014081797 | 2014-07-08 | ||
| PCT/US2015/023108 WO2015148984A2 (en) | 2014-03-27 | 2015-03-27 | Antibodies that bind human cannabinoid 1 (cb1) receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512838A JP2017512838A (ja) | 2017-05-25 |
| JP2017512838A5 true JP2017512838A5 (enExample) | 2018-05-17 |
| JP6598844B2 JP6598844B2 (ja) | 2019-10-30 |
Family
ID=53008849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502946A Active JP6598844B2 (ja) | 2014-03-27 | 2015-03-27 | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10308712B2 (enExample) |
| EP (2) | EP3122780B1 (enExample) |
| JP (1) | JP6598844B2 (enExample) |
| KR (2) | KR102553870B1 (enExample) |
| CN (1) | CN106232626B (enExample) |
| AU (1) | AU2015237275B2 (enExample) |
| CA (1) | CA2944049A1 (enExample) |
| CL (3) | CL2016002433A1 (enExample) |
| ES (1) | ES2915101T3 (enExample) |
| IL (1) | IL248006B2 (enExample) |
| MA (1) | MA39708A (enExample) |
| MX (1) | MX2016012403A (enExample) |
| PE (1) | PE20170258A1 (enExample) |
| RU (1) | RU2730674C2 (enExample) |
| TW (1) | TWI694086B (enExample) |
| WO (1) | WO2015148984A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122780B1 (en) * | 2014-03-27 | 2022-03-09 | Bird Rock Bio, Inc. | Antibodies that bind human cannabinoid 1 (cb1) receptor |
| JP2019502651A (ja) * | 2015-09-30 | 2019-01-31 | バード・ロック・バイオ・インコーポレイテッドＢｉｒｄ Ｒｏｃｋ Ｂｉｏ， Ｉｎｃ． | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
| AU2018282094B2 (en) | 2017-06-05 | 2024-06-27 | Janssen Biotech, Inc. | Antibodies that specifically bind PD-1 and methods of use |
| CN110914430B (zh) * | 2017-07-13 | 2023-11-21 | 协和麒麟株式会社 | 抗bril抗体以及使用了该抗体的bril融合蛋白质的稳定化方法 |
| CN108588071A (zh) * | 2018-04-25 | 2018-09-28 | 和元生物技术（上海）股份有限公司 | CRISPR-Cas9靶向敲除人肠癌细胞CNR1基因及其特异性的sgRNA |
| EP3787746A1 (en) * | 2018-04-30 | 2021-03-10 | Takeda Pharmaceutical Company Limited | Cannabinoid receptor type 1 (cb1) binding proteins and uses thereof |
| EP3823610A4 (en) * | 2018-07-17 | 2022-08-31 | The Regents of the University of California | METHODS OF TREATMENT OF KIDNEY DISEASE |
| EP3996747A4 (en) * | 2019-07-11 | 2023-08-16 | Tavotek Biotherapeutics (Hong Kong) Limited | AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN RECEPTOR (TSLP) SIGNALING |
| JP2025512973A (ja) * | 2022-04-04 | 2025-04-22 | バード ロック バイオ サブ， インコーポレイテッド | 急速進行性腎臓病の予測および処置 |
| CN119384505A (zh) | 2022-06-03 | 2025-01-28 | 盐野义制药株式会社 | 与大麻素1型受体结合的抗体 |
| WO2024022478A1 (zh) * | 2022-07-28 | 2024-02-01 | 长春金赛药业有限责任公司 | 结合大麻素受体cb1的抗体及其用途 |
| WO2024212999A1 (zh) * | 2023-04-11 | 2024-10-17 | 微境生物医药科技(上海)有限公司 | Cbl-b抑制剂 |
| CN118027211A (zh) * | 2024-04-11 | 2024-05-14 | 上海惠盾因泰生物科技有限公司 | 一种识别重组egf-crm197疫苗的单克隆抗体及其应用 |
| WO2026024319A1 (en) | 2024-07-23 | 2026-01-29 | Bird Rock Bio Sub, Inc. | Treatment of obesity and obstructive sleep apnea |
| CN120647762B (zh) * | 2025-06-16 | 2026-01-23 | 首都医科大学附属北京友谊医院 | 一种抗β1-AR-ECII抗体及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466579A (en) | 1987-12-28 | 1995-11-14 | Psychemedics Corporation | Hair analysis method |
| US5460785A (en) | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5817766A (en) | 1995-04-05 | 1998-10-06 | Roche Diagnostic Systems, Inc. | Reagents for a cannabinoid immunoassay |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| ES2637801T3 (es) | 2000-04-11 | 2017-10-17 | Genentech, Inc. | Anticuerpos multivalentes y usos de los mismos |
| US7214786B2 (en) | 2000-12-14 | 2007-05-08 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| CN1305905C (zh) | 2002-03-22 | 2007-03-21 | Aprogen株式会社 | 人源化抗体及其制备方法 |
| JP2007527389A (ja) * | 2003-06-30 | 2007-09-27 | メルク エンド カムパニー インコーポレーテッド | 放射性カンナビノイド−１受容体修飾因子 |
| US20050095674A1 (en) | 2003-07-23 | 2005-05-05 | Lewis Deborah L. | Cannabinoid receptor interacting proteins and methods of use |
| WO2005023232A2 (en) | 2003-09-04 | 2005-03-17 | Affibody Ab | Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| EP1574211A1 (en) | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| ITMI20041033A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Composti farmaceutici |
| WO2006047417A2 (en) | 2004-10-21 | 2006-05-04 | University Of Florida Research Foundation, Inc. | Detection of cannabinoid receptor biomarkers and uses thereof |
| EP1890767A2 (en) * | 2005-05-27 | 2008-02-27 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| EP2500352A1 (en) | 2005-08-19 | 2012-09-19 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| US8460362B2 (en) | 2006-07-20 | 2013-06-11 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| WO2008048648A2 (en) * | 2006-10-17 | 2008-04-24 | Acadia Pharmaceuticals Inc. | Cb1-modulating compounds and their use |
| NZ580887A (en) * | 2007-05-23 | 2012-03-30 | Merck Sharp & Dohme | Pyridyl piperidine orexin receptor antagonists |
| KR101649168B1 (ko) | 2008-05-09 | 2016-08-18 | 애브비 인코포레이티드 | 최종 당화 산물의 수용체(ｒａｇｅ)에 대한 항체 및 이의 용도 |
| FI20085579A0 (fi) | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
| IT1394400B1 (it) | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
| WO2010119704A1 (en) | 2009-04-17 | 2010-10-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| BR112013000841A2 (pt) * | 2010-07-15 | 2016-06-07 | Oleg Lliich Epshtein | composições farmacêuticas, métodos de tratamento da obesidade e distúrbios metabólicos relacionados, de redução da massa corpórea de mamífero, do crescimento da massa corpórea de mamífero, do consumo de comida em mamífero, de trtamento de paciente de adicção de substância psicoativa, de adicção de substância psicoativa e uso de forma ativada-potencializada de anticorpo para receptor de canabinoide humano. |
| UY33827A (es) | 2010-12-22 | 2012-07-31 | Abbott Lab | Proteínas de unión a media-inmunoglobulina y sus usos |
| US20120195900A1 (en) | 2010-12-22 | 2012-08-02 | Abbott Laboratories | Tri-variable domain binding proteins and uses thereof |
| US9435817B2 (en) | 2011-02-14 | 2016-09-06 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| US9441033B2 (en) | 2011-02-14 | 2016-09-13 | Randox Laboratories Limited | Detection of synthetic cannabinoids |
| GB201102544D0 (en) | 2011-02-14 | 2011-03-30 | Randox Lab Ltd | Assay |
| PT2709631T (pt) | 2011-05-20 | 2017-04-19 | Inserm - Inst Nat De La Santé Et De La Rech Médicale | Antagonistas de receptor de cb1 |
| US8758826B2 (en) * | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| EP2698383B1 (en) | 2012-08-14 | 2020-11-25 | Randox Laboratories Ltd. | Detection of synthetic Cannabinoids |
| AU2014302410B2 (en) | 2013-06-26 | 2019-06-13 | Amgen Inc. | CB1 receptor antigen-binding proteins and uses thereof |
| KR20160097336A (ko) | 2013-12-12 | 2016-08-17 | 스템센트알엑스 인코포레이티드 | 신규 항-ｄｐｅｐ3 항체 및 이의 사용 방법 |
| EP3122780B1 (en) * | 2014-03-27 | 2022-03-09 | Bird Rock Bio, Inc. | Antibodies that bind human cannabinoid 1 (cb1) receptor |
-
2015
- 2015-03-27 EP EP15719033.1A patent/EP3122780B1/en active Active
- 2015-03-27 ES ES15719033T patent/ES2915101T3/es active Active
- 2015-03-27 TW TW104110160A patent/TWI694086B/zh active
- 2015-03-27 RU RU2016141919A patent/RU2730674C2/ru active
- 2015-03-27 MA MA039708A patent/MA39708A/fr unknown
- 2015-03-27 PE PE2016001719A patent/PE20170258A1/es unknown
- 2015-03-27 AU AU2015237275A patent/AU2015237275B2/en active Active
- 2015-03-27 EP EP22160342.6A patent/EP4159761A1/en active Pending
- 2015-03-27 US US14/774,582 patent/US10308712B2/en active Active
- 2015-03-27 CA CA2944049A patent/CA2944049A1/en active Pending
- 2015-03-27 KR KR1020167029997A patent/KR102553870B1/ko active Active
- 2015-03-27 MX MX2016012403A patent/MX2016012403A/es unknown
- 2015-03-27 WO PCT/US2015/023108 patent/WO2015148984A2/en not_active Ceased
- 2015-03-27 IL IL248006A patent/IL248006B2/en unknown
- 2015-03-27 CN CN201580015645.5A patent/CN106232626B/zh active Active
- 2015-03-27 JP JP2017502946A patent/JP6598844B2/ja active Active
- 2015-03-27 KR KR1020237022858A patent/KR102731863B1/ko active Active
-
2016
- 2016-09-27 CL CL2016002433A patent/CL2016002433A1/es unknown
-
2019
- 2019-01-25 US US16/257,511 patent/US11566069B2/en active Active
- 2019-03-27 CL CL2019000799A patent/CL2019000799A1/es unknown
-
2021
- 2021-10-08 CL CL2021002637A patent/CL2021002637A1/es unknown
-
2023
- 2023-01-27 US US18/160,745 patent/US20230348589A1/en not_active Abandoned
-
2024
- 2024-10-08 US US18/909,574 patent/US20250236669A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512838A5 (enExample) | ||
| RU2016141919A (ru) | Антитела, связывающиеся с человеческим каннабиноидным рецептором 1 (св1) | |
| JP6681433B2 (ja) | Ｐ２ｘ７受容体アンタゴニスト及びアゴニスト | |
| AU2018312222B2 (en) | Anti-CD47 antibodies and uses thereof | |
| JP7273110B2 (ja) | 高親和性抗ｖｅｇｆ抗体 | |
| JP2018503380A5 (enExample) | ||
| JP2020501531A5 (enExample) | ||
| JP2017526370A5 (enExample) | ||
| JP2012501669A5 (enExample) | ||
| TW202144417A (zh) | Ｐｖｒｉｇ結合蛋白及其醫藥用途 | |
| JP2008516970A5 (enExample) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| JP2012501670A5 (enExample) | ||
| JP2014500009A5 (enExample) | ||
| JP2013502913A5 (enExample) | ||
| JP2015530971A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2011207882A5 (enExample) | ||
| JP2015533853A5 (enExample) | ||
| JP2022507679A (ja) | Ｈｅｒ２／ｐｄ１二重特異性抗体 | |
| JP2017505622A5 (enExample) | ||
| JP2013538057A5 (enExample) | ||
| JP2014524733A5 (enExample) | ||
| TWI869528B (zh) | C5ar1抗體分子及其用途 | |
| US20240101675A1 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof |